Vaccine-Associated Paralytic Poliomyelitis: A Review of the Epidemiology and Estimation of the Global Burden
Open Access
- 14 October 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 210 (suppl 1), S380-S389
- https://doi.org/10.1093/infdis/jiu184
Abstract
Background. Vaccine-associated paralytic poliomyelitis (VAPP) is a rare adverse event associated with oral poliovirus vaccine (OPV). This review summarizes the epidemiology and provides a global burden estimate. Methods. A literature review was conducted to abstract the epidemiology and calculate the risk of VAPP. A bootstrap method was applied to calculate global VAPP burden estimates. Results. Trends in VAPP epidemiology varied by country income level. In the low-income country, the majority of cases occurred in individuals who had received >3 doses of OPV (63%), whereas in middle and high-income countries, most cases occurred in recipients after their first OPV dose or unvaccinated contacts (81%). Using all risk estimates, VAPP risk was 4.7 cases per million births (range, 2.4–9.7), leading to a global annual burden estimate of 498 cases (range, 255–1018). If the analysis is limited to estimates from countries that currently use OPV, the VAPP risk is 3.8 cases per million births (range, 2.9–4.7) and a burden of 399 cases (range, 306–490). Conclusions. Because many high-income countries have replaced OPV with inactivated poliovirus vaccine, the VAPP burden is concentrated in lower-income countries. The planned universal introduction of inactivated poliovirus vaccine is likely to substantially decrease the global VAPP burden by 80%–90%.Keywords
This publication has 42 references indexed in Scilit:
- Impacto económico de la introducción de la vacuna inactivada inyectable contra la poliomielitis en ColombiaRevista Panamericana de Salud Pública, 2010
- Ocorrência de poliomielite associada à vacina no Brasil, 1995 a 2001Revista Panamericana de Salud Pública, 2005
- Surveillance of suspected poliomyelitis in Albania, 1980?1995: suggestion of increased risk of vaccine associated poliomyelitisVaccine, 1998
- Vaccine-associated cases of poliomyelitis over a 30 year period in East GermanyEuropean Journal of Epidemiology, 1995
- Paralytic poliomyelitis in England and Wales, 1985-91.BMJ, 1992
- Epidemiology of Poliomyelitis in the United States One Decade after the Last Reported Case of Indigenous Wild Virus-Associated DiseaseClinical Infectious Diseases, 1992
- Factors Affecting the Immunogenicity of Oral Poliovirus Vaccine in Developing Countries: ReviewClinical Infectious Diseases, 1991
- Paralytic poliomyelitis in England & Wales, 1970–84Epidemiology and Infection, 1987
- Experiences Associated with the Use of Live Poliovirus Vaccine in Hungary, 1959–1982Clinical Infectious Diseases, 1984
- Poliomyelitis surveillance in England and Wales, 1969–1975Epidemiology and Infection, 1978